CardiacAssist, Inc. Announces The First Human Use Of Its PROTEK DUO™ Veno-Venous ECLS Kit

PITTSBURGH--(BUSINESS WIRE)--CardiacAssist, Inc. today announced that the first PROTEK Duo veno-venous extracorporeal life support (VV ECLS) kit was utilized on Wednesday, September 24th, at Memorial Hermann Hospital in Houston, Texas. According to statements from the world-renowned heart failure team led by Dr. Biswajit Kar, Dr. Pranav Loyalka and Dr. Igor Gregoric, the PROTEK Duo ECLS kit was utilized when one patient’s heart function continued to deteriorate despite the successful implantation of a long-term left ventricular assist device (LVAD).

The PROTEK Duo cannula was placed during a short, minimally-invasive percutaneous procedure in the cardiac catheterization lab before returning the patient to the hospital’s cardiac intensive care unit, where many of the pharmaceuticals upon which the patient was dependent were able to be weaned. In combination with the TandemHeart® pump, the PROTEK Duo was reported to deliver 4.0 Liters per minute of blood flow, allowing the patient’s native heart to rest while augmenting flow to the implantable LVAD. The patient is now in the process of being weaned from the device and the outlook is favorable despite a long road to full recovery.

Help employers find you! Check out all the jobs and post your resume.

Back to news